Lanean...
Clinical Experience with Daptomycin for the Treatment of Gram-positive Infections in Children and Adolescents
BACKGROUND: This subgroup analysis of the European Cubicin Outcomes Registry Experience evaluated the safety and effectiveness of daptomycin in children and adolescent patients (<18 years). METHODS: Clinical outcomes at the end of therapy were assessed as success (cured or improved), failure or n...
Gorde:
| Argitaratua izan da: | Pediatr Infect Dis J |
|---|---|
| Egile Nagusiak: | , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Williams & Wilkins
2016
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4830747/ https://ncbi.nlm.nih.gov/pubmed/26849158 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/INF.0000000000001076 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|